Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
These re-agent and diagnostic test kits come with 99.7% accuracy
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Subscribe To Our Newsletter & Stay Updated